Anticoagulation with direct-acting anticoagulants decreases the risk of cardiovascular adverse events in patients with heart failure and atrial fibrillation compared to acenocoumarol

被引:0
|
作者
Gonzalez Leal, A. [1 ]
Sanchez Vega, J. D. [1 ]
Antonana Ugalde, S. [1 ]
Arteagoitia Bolumburu, A. [1 ]
Alvarez-Garcia, J. [1 ]
Del Prado, S. [1 ]
Cordero, D. [1 ]
Jimenez-Blanco, M. [1 ]
Castillo, M. [1 ]
Gonzalez Ferrer, E. [1 ]
Zamorano, J. L. [1 ]
Alonso Salinas, G. L. [2 ]
机构
[1] Hosp Ramon & Cajal, Cardiol Dept, Madrid, Spain
[2] Hosp Complex Navarra, Pamplona, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:287 / 287
页数:1
相关论文
共 50 条
  • [1] Direct-acting oral anticoagulants in patients with atrial fibrillation and valvular heart disease
    Canales, Natalie
    Cao, Tina
    Fakourfar, Neeloufar
    Snee, Mara
    Tsu, Laura
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 17 - 18
  • [2] Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events
    Acton, Emily K.
    Hennessy, Sean
    Gelfand, Michael A.
    Leonard, Charles E.
    Bilker, Warren B.
    Shu, Di
    Willis, Allison W.
    Kasner, Scott E.
    JAMA NEUROLOGY, 2024, 81 (08) : 835 - 844
  • [3] BLEEDING RISK OF DIRECT ORAL ANTICOAGULANTS COMPARED WITH WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE
    Lu, Lingyun
    Warner, Alberta
    Ghaznavi, Zunera
    Chang, Donald
    Tubert, Nikolas
    Jackevicius, Cynthia
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 900 - 900
  • [4] Prescribing and Safety of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients with Atrial Fibrillation on Chronic Hemodialysis
    Davis, Estella
    Darais, Dallin
    Fuji, Kevin
    Nekola, Paige
    Bashir, Khalid
    PHARMACY, 2020, 8 (01)
  • [5] A novel bleeding risk prediction tool for patients with atrial fibrillation on direct-acting oral anticoagulants
    Estes, N. A. Mark
    HEART RHYTHM, 2023, 20 (12)
  • [6] Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation
    Jackevicius, Cynthia A.
    Lu, Lingyun
    Ghaznavi, Zunera
    Warner, Alberta L.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (02): : 155 - 168
  • [7] Safety of the direct-acting anticoagulants in patients with atrial fibrillation: a meta-analysis
    Rong, Fen
    Jia, Bin
    Huang, Pinxian
    Lynn, Henry S.
    Zhang, Wei
    THROMBOSIS RESEARCH, 2015, 135 (06) : 1117 - 1123
  • [8] Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy: Risk of Thromboembolic and Major Bleeding Events
    Acton, Emily K.
    Hennessy, Sean
    Gelfand, Michael A.
    Leonard, Charles E.
    Bilker, Warren B.
    Shu, Di
    Willis, Allison W.
    Kasner, Scott E.
    STROKE, 2024, 55
  • [9] Evaluation of the Safety and Effectiveness of Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation and Coexisting Valvular Heart Disease
    Hampton, Meredith L.
    Tellor, Katie B.
    Armbruster, Anastasia L.
    Theodos, Gus
    Schwarze, Martin W.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (06) : 611 - 617
  • [10] Evaluation of the Safety and Effectiveness of Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation and Coexisting Valvular Heart Disease
    Meredith L. Hampton
    Katie B. Tellor
    Anastasia L. Armbruster
    Gus Theodos
    Martin W. Schwarze
    American Journal of Cardiovascular Drugs, 2020, 20 : 611 - 617